GSK’s Malaria Vaccine Containing Agenus’ QS-21 Stimulon® Receives Positive Opinion from European Regulators for Prevention of Malaria in Young Children in Sub-Saharan Africa
Go back to GSK’s Malaria Vaccine Containing Agenus’ QS-21 Stimulon® Receives Positive Opinion from European Regulators for Prevention of Malaria in Young Children in Sub-Saharan Africa| AGENUS (NASDAQ: AGEN) | Delayed: 7.61 -0.63 (7.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.24 | 52 Week High | $7.49 | |||
| Open | $8.14 | 52 Week Low | $2.61 | |||
| Day High | $8.18 | P/E | N/A | |||
| Day Low | $7.59 | EPS | $-1.10 | |||
| Volume | 773,958 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 48.66 -1.23 (2.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.89 | 52 Week High | $45.58 | |||
| Open | $49.00 | 52 Week Low | $37.82 | |||
| Day High | $49.23 | P/E | N/A | |||
| Day Low | $48.54 | EPS | $0.00 | |||
| Volume | 2,259,802 | |||||

